-
公开(公告)号:US20060252780A1
公开(公告)日:2006-11-09
申请号:US10554254
申请日:2004-04-23
申请人: Takao Nakajima , Kimihisa Ueno , Yuji Nomoto , Yuichi Matsumoto , Hiroshi Yano , Satoshi Nakanishi , Kotaro Takasaki , Hideaki Kusaka
发明人: Takao Nakajima , Kimihisa Ueno , Yuji Nomoto , Yuichi Matsumoto , Hiroshi Yano , Satoshi Nakanishi , Kotaro Takasaki , Hideaki Kusaka
IPC分类号: A61K31/519 , C07D487/14
CPC分类号: C07D487/14
摘要: A fused pyrimidine derivative is presented. The derivatie has an insulin secretion stimulating activity represented by Formula (I): {wherein R1 represents a hydrogen atom, lower alkyl, or the like; n represents an integer of 0 to 3; and X1 and X2 may be the same or different and each represents a hydrogen atom, lower alkyl, or the like; and formula (II): represents formula (III): [wherein X—Y—Z represents R2C═CR3—NR4 (wherein R2, R3 and R4 may be the same or different and each represents a hydrogen atom, lower alkyl, or the like)]}, or a pharmaceutically acceptable salt thereof.
摘要翻译: 提出了一种稠合的嘧啶衍生物。 衍生物具有由式(I)表示的胰岛素分泌刺激活性:其中R 1表示氢原子,低级烷基等; n表示0〜3的整数, X 1和X 2可以相同或不同,各自表示氢原子,低级烷基等; 和式(II):表示式(III):[其中XYZ表示R 2 C-CR 3 -NR 4(其中R' O 2,R 3和R 4可以相同或不同,各自表示氢原子,低级烷基等)]}, 或其药学上可接受的盐。
-
公开(公告)号:US07005430B2
公开(公告)日:2006-02-28
申请号:US10149423
申请日:2000-12-22
申请人: Kimihisa Ueno , Akira Ogawa , Yoshihisa Ohta , Yuji Nomoto , Kotaro Takasaki , Hideaki Kusaka , Hiroshi Yano , Chiharu Nakagawa , Satoshi Nakanishi
发明人: Kimihisa Ueno , Akira Ogawa , Yoshihisa Ohta , Yuji Nomoto , Kotaro Takasaki , Hideaki Kusaka , Hiroshi Yano , Chiharu Nakagawa , Satoshi Nakanishi
IPC分类号: C07D487/14 , C07D473/24 , C07D473/22 , A61K31/519 , A61P3/10
CPC分类号: C07D487/14
摘要: A condensed purine derivative represented by Formula (I): wherein X—Y-Z represents R1N—C═O or N═C—W, R2 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted alicyclic heterocyclic group or the like, n represents an integer of from 0 to 3, V1 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aromatic heterocyclic group, V2 represents a substituted lower alkyl group or a substituted or unsubstituted aromatic heterocyclic group, and when V1 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group, and for example, X—Y-Z represents R1aN—C═O and R2 represents a substituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted alicyclic heterocyclic group, a halogen atom, a lower alkylthio group, —NR7R8, —CO2H, a lower alkoxycarbonyl group, —COHal, —CONR9R10 or —CHO, V2 may represent a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group; or a pharmacologically acceptable salt thereof.
摘要翻译: 由式(I)表示的稠合嘌呤衍生物:化学式id =“CHEM-US-00001”num =“000”
-
公开(公告)号:US07718808B2
公开(公告)日:2010-05-18
申请号:US10584633
申请日:2004-12-24
申请人: Takao Nakajima , Masamori Sugawara , Shin-ichi Uchida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
发明人: Takao Nakajima , Masamori Sugawara , Shin-ichi Uchida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
IPC分类号: A61K31/427 , C07D417/14
CPC分类号: C07D417/06 , A61K31/427 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/4985 , A61K31/501 , A61K31/506 , A61K31/5383 , A61K31/541 , A61K31/542 , A61K31/551 , A61K31/553 , A61K31/695 , C07D417/04 , C07D417/14 , C07D491/048 , C07D491/10 , C07D498/04 , C07D513/04
摘要: (Wherein n is an integer of from 0 to 3; R1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, or a substituted or unsubstituted aromatic heterocyclic group; R2 is halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, a substituted or unsubstituted aromatic heterocyclic group, —COR8, or the like; R3 and R4 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, —COR12, or the like)For example, provided are adenosine A2A receptor antagonists comprising, as the active ingredient, a thiazole derivative represented by a general formula (I), or a pharmaceutically acceptable salt thereof, and the like.
摘要翻译: 本发明提供的腺苷A 2A受体拮抗剂包含作为活性成分的由通式(I)表示的噻唑衍生物或其药学上可接受的盐:......(其中n为0-3的整数; R 1为取代或 取代或未取代的芳基,取代或未取代的脂环族杂环基或取代或未取代的芳族杂环基; R2为卤素,取代或未取代的低级烷基,取代或未取代的芳基,取代或未取代的脂环族杂环基, 或未取代的芳族杂环基,-COR 8等; R 3和R 4可以相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的芳烷基,-COR 12等)。
-
公开(公告)号:US08420827B2
公开(公告)日:2013-04-16
申请号:US12960937
申请日:2010-12-06
申请人: Takao Nakajima , Masamori Sugawara , Shin-ichi Uchida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
发明人: Takao Nakajima , Masamori Sugawara , Shin-ichi Uchida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
IPC分类号: A61K31/427 , C07D417/14
CPC分类号: C07D417/06 , A61K31/427 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/4985 , A61K31/501 , A61K31/506 , A61K31/5383 , A61K31/541 , A61K31/542 , A61K31/551 , A61K31/553 , A61K31/695 , C07D417/04 , C07D417/14 , C07D491/048 , C07D491/10 , C07D498/04 , C07D513/04
摘要: Wherein n is an integer of from 0 to 3; R1A is a 5-membered aromatic heterocyclic group containing at least one oxygen atom; R2A is —COR8 (wherein R8 is aryl); R3A is hydrogen or lower alkyl; and R12 represents cycloalkyl, aryl, aralkyl, alicyclic heterocyclic group, aromatic heterocyclic group, alicyclic hetocyclic-alkyl, or aromatic heterocyclic-alkyl, and R1A, R2A, R3A and R12 are individually optionally substituted.
摘要翻译: - 根据式(1A)的化合物,其中n为0至3的整数; R1A是含有至少一个氧原子的5元芳族杂环基; R2A是-COR8(其中R8是芳基); R3A是氢或低级烷基; R 12表示环烷基,芳基,芳烷基,脂环族杂环基,芳香族杂环基,脂环族环状烷基或芳香族杂环烷基,R1A,R2A,R3A,R12分别任选被取代,及其药学上可接受的盐。
-
公开(公告)号:US07880013B2
公开(公告)日:2011-02-01
申请号:US12766986
申请日:2010-04-26
IPC分类号: A61K31/427 , C07D417/14
CPC分类号: C07D417/06 , A61K31/427 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/4985 , A61K31/501 , A61K31/506 , A61K31/5383 , A61K31/541 , A61K31/542 , A61K31/551 , A61K31/553 , A61K31/695 , C07D417/04 , C07D417/14 , C07D491/048 , C07D491/10 , C07D498/04 , C07D513/04
摘要: (Wherein n is an integer of from 0 to 3; R1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, or a substituted or unsubstituted aromatic heterocyclic group; R2 is halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, a substituted or unsubstituted aromatic heterocyclic group, —COR8, or the like; R3 and R4 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, —COR12, or the like)For example, provided are adenosine A2A receptor antagonists comprising, as the active ingredient, a thiazole derivative represented by a general formula (I), or a pharmaceutically acceptable salt thereof, and the like.
摘要翻译: 本发明提供的腺苷A 2A受体拮抗剂包含作为活性成分的通式(I)所示的噻唑衍生物或其药学上可接受的盐等(其中,n为0〜3的整数,R1为 取代或未取代的环烷基,取代或未取代的芳基,取代或未取代的脂环族杂环基或取代或未取代的芳族杂环基; R2为卤素,取代或未取代的低级烷基,取代或未取代的芳基,取代或未取代的脂环族杂环基, 取代或未取代的芳族杂环基,-COR 8等; R 3和R 4可以相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的芳烷基,-COR 12等) 。
-
公开(公告)号:US20070105919A1
公开(公告)日:2007-05-10
申请号:US10584633
申请日:2004-12-24
申请人: Takao Nakajima , Masamori Sugawara , Shin-ichi Ushida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
发明人: Takao Nakajima , Masamori Sugawara , Shin-ichi Ushida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
IPC分类号: A61K31/427
CPC分类号: C07D417/06 , A61K31/427 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/4985 , A61K31/501 , A61K31/506 , A61K31/5383 , A61K31/541 , A61K31/542 , A61K31/551 , A61K31/553 , A61K31/695 , C07D417/04 , C07D417/14 , C07D491/048 , C07D491/10 , C07D498/04 , C07D513/04
摘要: (Wherein n is an integer of from 0 to 3; R1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, or a substituted or unsubstituted aromatic heterocyclic group; R2 is halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, a substituted or unsubstituted aromatic heterocyclic group, —COR8, or the like; R3 and R4 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, —COR12, or the like) For example, provided are adenosine A2A receptor antagonists comprising, as the active ingredient, a thiazole derivative represented by a general formula (I), or a pharmaceutically acceptable salt thereof, and the like.
摘要翻译: (其中n为0-3的整数; R 1是取代或未取代的环烷基,取代或未取代的芳基,取代或未取代的脂环族杂环基或取代或未取代的芳族杂环基; R 取代或未取代的芳基,取代或未取代的脂环族杂环基,取代或未取代的芳族杂环基,-COR 8或 R 3和R 4可以相同或不同,并且各自表示氢原子,取代或未取代的低级烷基,取代或未取代的芳烷基,-COR 3, 例如,提供了包含作为活性成分的由通式(I)表示的噻唑衍生物或腺苷A 2A受体拮抗剂的腺苷A 2A受体拮抗剂,或 药学上可接受的盐等。
-
公开(公告)号:US20110105486A1
公开(公告)日:2011-05-05
申请号:US12960937
申请日:2010-12-06
申请人: Takao Nakajima , Masamori Sugawara , Shin-ichi Uchida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
发明人: Takao Nakajima , Masamori Sugawara , Shin-ichi Uchida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
IPC分类号: A61K31/541 , C07D277/38 , C07D417/14 , C07D401/14 , C07D213/89 , C07D413/14 , C07D279/12 , A61K31/426 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61P25/28 , A61P25/00 , A61P3/10 , A61P25/12 , A61P25/24
CPC分类号: C07D417/06 , A61K31/427 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/4985 , A61K31/501 , A61K31/506 , A61K31/5383 , A61K31/541 , A61K31/542 , A61K31/551 , A61K31/553 , A61K31/695 , C07D417/04 , C07D417/14 , C07D491/048 , C07D491/10 , C07D498/04 , C07D513/04
摘要: Wherein n is an integer of from 0 to 3; R1A is a 5-membered aromatic heterocyclic group containing at least one oxygen atom; R2A is —COR8 (wherein R8 is aryl); R3A is hydrogen or lower alkyl; and R12 represents cycloalkyl, aryl, aralkyl, alicyclic heterocyclic group, aromatic heterocyclic group, alicyclic hetocyclic-alkyl, or aromatic heterocyclic-alkyl, and R1A, R2A, R3A and R12 are individually optionally substituted.
摘要翻译: 其中n为0至3的整数; R1A是含有至少一个氧原子的5元芳族杂环基; R2A是-COR8(其中R8是芳基); R3A是氢或低级烷基; R 12表示环烷基,芳基,芳烷基,脂环族杂环基,芳香族杂环基,脂环族环状烷基或芳香族杂环烷基,R1A,R2A,R3A,R12分别任意取代。
-
公开(公告)号:US20100256361A1
公开(公告)日:2010-10-07
申请号:US12766986
申请日:2010-04-26
申请人: Takao Nakajima , Masamori Sugawara , Shin-ichi Uchida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
发明人: Takao Nakajima , Masamori Sugawara , Shin-ichi Uchida , Tetsuji Ohno , Yuji Nomoto , Noriaki Uesaka , Yoshisuke Nakasato
IPC分类号: C07D417/14 , C07D413/14 , C07D498/04
CPC分类号: C07D417/06 , A61K31/427 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/4985 , A61K31/501 , A61K31/506 , A61K31/5383 , A61K31/541 , A61K31/542 , A61K31/551 , A61K31/553 , A61K31/695 , C07D417/04 , C07D417/14 , C07D491/048 , C07D491/10 , C07D498/04 , C07D513/04
摘要: (Wherein n is an integer of from 0 to 3; R1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, or a substituted or unsubstituted aromatic heterocyclic group; R2 is halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, a substituted or unsubstituted alicyclic heterocyclic group, a substituted or unsubstituted aromatic heterocyclic group, —COR8, or the like; R3 and R4 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, —COR12, or the like)For example, provided are adenosine A2A receptor antagonists comprising, as the active ingredient, a thiazole derivative represented by a general formula (I), or a pharmaceutically acceptable salt thereof, and the like.
摘要翻译: (其中n为0〜3的整数; R 1为取代或未取代的环烷基,取代或未取代的芳基,取代或未取代的脂环族杂环基或取代或未取代的芳香族杂环基; R2为卤素,取代或未取代的低级烷基 取代或未取代的芳基,取代或未取代的脂环族杂环基,取代或未取代的芳族杂环基,-COR 8等; R 3和R 4可以相同或不同,表示氢原子,取代或未取代的低级 烷基,取代或未取代的芳烷基,-COR 12等)例如,提供的是腺苷A 2A受体拮抗剂,其包含作为活性成分的由通式(I)表示的噻唑衍生物或其药学上可接受的盐,以及 类似。
-
公开(公告)号:US20100226803A1
公开(公告)日:2010-09-09
申请号:US12784529
申请日:2010-05-21
申请人: Fumio TAJIMA , Masashi Kitamura , Yuji Enomoto , Yuji Nomoto , Kenya Takarai
发明人: Fumio TAJIMA , Masashi Kitamura , Yuji Enomoto , Yuji Nomoto , Kenya Takarai
CPC分类号: F04D13/064 , B60L1/003 , B60L1/02 , B60L3/0061 , B60L11/14 , B60L2210/40 , B60L2240/34 , B60L2240/36 , B60L2240/425 , B60L2270/142 , B60L2270/145 , F04D13/0633 , H02K1/02 , H02K1/145 , H02K5/12 , H02K7/14 , H02K21/145 , Y02T10/641 , Y02T10/642 , Y02T10/70 , Y02T10/7077 , Y02T10/7241
摘要: A pump is driven by a compact electric motor in which a coil is disposed in a ring form around and along a stator core which has a plurality of claw magnetic poles that extend alternately from both ends of one member of the stator core toward the end of the other member thereof. A stator core can be made from a compressed powder core by molding with resin, with the molded portion able to serve as a partition separating pump and motor units.
-
公开(公告)号:US06270314B1
公开(公告)日:2001-08-07
申请号:US09397149
申请日:1999-09-16
申请人: Yuji Nomoto
发明人: Yuji Nomoto
IPC分类号: F04D2916
CPC分类号: F04D29/426 , F04D29/086 , F04D29/167
摘要: A water pump for an internal combustion engine having a pump casing and a pump cover that forms a circulation cavity. A plate is positioned interface of the pump casing and the pump cover and divides the circulation cavity into an inlet passage and an outlet passage and has a seal portion that seals against the leakage between the inlet passage and the outlet passage of a gap of the interface of the pump casing and the pump cover.
摘要翻译: 一种用于内燃机的水泵,其具有形成循环腔的泵壳体和泵盖。 板被定位在泵壳体和泵盖的界面上,并将循环腔分成入口通道和出口通道,并且具有密封部分,该密封部分密封入口通道和出口通道之间的界面间隙的泄漏 的泵壳和泵盖。
-
-
-
-
-
-
-
-
-